GE HealthCare Technologies (NASDAQ:GEHC) Given New $97.00 Price Target at Wells Fargo & Company

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective increased by Wells Fargo & Company from $95.00 to $97.00 in a research report report published on Thursday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other analysts also recently issued reports on GEHC. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price target for the company from $73.00 to $77.00 in a report on Thursday, January 15th. BTIG Research lifted their price objective on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday. Morgan Stanley upped their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday. Jefferies Financial Group raised their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Finally, Piper Sandler boosted their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $92.42.

GE HealthCare Technologies Trading Down 0.4%

Shares of GEHC stock opened at $82.31 on Thursday. The business’s fifty day moving average price is $82.72 and its 200 day moving average price is $77.50. GE HealthCare Technologies has a 1-year low of $57.65 and a 1-year high of $94.80. The firm has a market capitalization of $37.49 billion, a PE ratio of 18.05, a P/E/G ratio of 2.46 and a beta of 1.08. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s payout ratio is 2.89%.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors have recently bought and sold shares of the business. Laurel Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies during the 4th quarter worth $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $27,000. Montag A & Associates Inc. lifted its stake in shares of GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares in the last quarter. Godsey & Gibb Inc. acquired a new position in shares of GE HealthCare Technologies during the third quarter worth about $26,000. Finally, E Fund Management Hong Kong Co. Ltd. boosted its position in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 results and outlook beat — GEHC reported $1.44 EPS (vs. $1.40 est.) and $5.7B revenue (vs. $5.6B est.), and raised FY‑2026 EPS guidance to $4.95–5.15 (above consensus), a key driver of recent optimism. GE HealthCare reports fourth quarter and full year 2025 financial results
• Positive Sentiment: Evercore ISI raised its price target to $98 with an “outperform” rating ( ~19% upside from current levels), signalling continued analyst confidence after the quarter. Benzinga
• Positive Sentiment: Wells Fargo boosted its PT to $97 and kept an “overweight” rating, citing the stronger results/guidance as support for higher estimates. Benzinga
• Positive Sentiment: BTIG raised its price target to $91 and maintained a “buy” call, another vote of confidence from the sell side after the quarter. GE HealthCare (GEHC) PT Raised to $91 at BTIG
• Neutral Sentiment: Market commentary is bullish on further upside — pieces noting the post‑earnings “pop” argue room remains to run, but they largely reflect sentiment rather than new fundamentals. GE HealthCare Technologies Pops, And The Upside Isn’t Over Yet
• Negative Sentiment: Margin pressure noted — several reports highlight a slide in net margin driven by tariffs and product mix, which tempers the EPS beat and could limit multiple expansion. GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
• Negative Sentiment: Coverage notes profit fell despite higher revenue — the WSJ and others emphasize the profitability hit, a reminder that growth is not yet fully translating into margin expansion. GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.